News & Views
Novel cancer treatment identified
Nov 08 2011
Posted by Ben Evens
Scientists have made a breakthrough in pioneering work for the treatment of cancer.
ImmunAid Pty have been awarded a European patent for its work with cancer, which involved monitoring the immune cycle of individual patients to determine the best time to administer treatment.
"The discovery of the regulated immune response cycle in cancer patients is potentially of immense clinical significance with profound public health implications," Dr Svetomir Markovic, chair of the Melanoma Group at Mayo Clinic in Rochester, Minnesota.
Research by the scientists determined that the immune system of all cancer patients moves in a repeating cycle, highlighting that administering treatment at key points in this cycle can significantly improve their clinical outcome.
Further investigation is underway into the cyclic treatment process, including into other types of cancer as well as diseases such as multiple sclerosis and human immunodeficiency virus (HIV).
Recently, researchers at the University of Texas MD Anderson Cancer Center found that a key protein plays a surprising role in cancer formation.
Digital Edition
International Labmate Buyers' Guide 2024/25
June 2024
Buyers' Guide featuring: Product Listings & Manufacturers Directory Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters - Digital transformatio...
View all digital editions
Events
Jul 07 2024 Dublin, Ireland
Jul 20 2024 Denver, CO, USA
Jul 21 2024 Cape Town, South Africa
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia